mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for HOXB1
Gene summary
Basic gene Info.Gene symbolHOXB1
Gene namehomeobox B1
SynonymsHCFP3|HOX2|HOX2I|Hox-2.9
CytomapUCSC genome browser: 17q21.3
Type of geneprotein-coding
RefGenesNM_002144.3,
Descriptionhomeobox protein Hox-2Ihomeobox protein Hox-B1
Modification date20141207
dbXrefs MIM : 142968
HGNC : HGNC
HPRD : 00855
ProteinUniProt: P14653
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_HOXB1
BioGPS: 3211
PathwayNCI Pathway Interaction Database: HOXB1
KEGG: HOXB1
REACTOME: HOXB1
Pathway Commons: HOXB1
ContextiHOP: HOXB1
ligand binding site mutation search in PubMed: HOXB1
UCL Cancer Institute: HOXB1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for HOXB1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R233R232QBLCA1
K259R261HKIRC1
R233R233SLUAD1
M256M256ILUAD1
Q246E244KSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for HOXB1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R233R232Q-1.2315194
Q246E244K-1.0324531
K259R261H-1.0096639
M256M256I-0.9622457
R233R233S-0.7977343
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for HOXB1 from PDB

Top
Differential gene expression and gene-gene network for HOXB1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of HOXB1 and the right PPI network was created from samples without mutations in the LBS of HOXB1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for HOXB1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C3553625FACIAL PARESIS, HEREDITARY CONGENITAL, 31GeneticVariation
umls:C0376634Craniofacial Abnormalities1Biomarker
umls:C1858717Facial paresis, hereditary, congenital1Biomarker
umls:C0497552Nervous System Malformations1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for HOXB1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of HOXB1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids1b72AQ246
NUCNucleic Acids1b72AR233 M256 K259


Top
Conservation information for LBS of HOXB1
Multiple alignments for P14653 in multiple species
LBSAA sequence# speciesSpecies
F210GLRTNFTTRQL4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
I249ETQVKIWFQNR4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
K248NETQVKIWFQN4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
K257QNRRMKQKKRE4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
K259RRMKQKKRERE4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
M256FQNRRMKQKKR4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
N253KIWFQNRRMKQ4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
Q246ELNETQVKIWF4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
Q252VKIWFQNRRMK4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
R207SPSGLRTNFTT3Homo sapiens, Pan troglodytes, Macaca mulatta
R207APGGLRTNFTT1Mus musculus
R233LSRARRVEIAA4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
R255WFQNRRMKQKK4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
T208PSGLRTNFTTR3Homo sapiens, Pan troglodytes, Macaca mulatta
T208PGGLRTNFTTR1Mus musculus
W250TQVKIWFQNRR4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta
Y227FHFNKYLSRAR4Homo sapiens, Mus musculus, Pan troglodytes, Macaca mulatta


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas